These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29791895)

  • 101. Efficacy and safety comparative study of dexrabeprazole vs. esomeprazole for the treatment of gastroesophageal reflux disease.
    Abdo-Francis JM; Cabrera-Álvarez G; Martínez-Torres H; Remes-Troche JM
    Gac Med Mex; 2022; 158(6):423-429. PubMed ID: 36657136
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study.
    Shaheen NJ; Crockett SD; Bright SD; Madanick RD; Buckmire R; Couch M; Dellon ES; Galanko JA; Sharpless G; Morgan DR; Spacek MB; Heidt-Davis P; Henke D
    Aliment Pharmacol Ther; 2011 Jan; 33(2):225-34. PubMed ID: 21083673
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Observational study in primary health care: symptoms control of gastroesophageal reflux disease and influence on the quality of life].
    Krstić M; Damjanov D; Ngorni A
    Srp Arh Celok Lek; 2013; 141(1-2):54-60. PubMed ID: 23539911
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Quality of life, patient satisfaction, and disease burden in patients with gastroesophageal reflux disease with or without laryngopharyngeal reflux symptoms.
    Gong EJ; Choi KD; Jung HK; Youn YH; Min BH; Song KH; Huh KC
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1336-1340. PubMed ID: 28052406
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy.
    Mayanagi S; Kishino M; Kitagawa Y; Sunamura M
    Tohoku J Exp Med; 2014 Nov; 234(3):237-40. PubMed ID: 25382232
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Surgical cure of primary hyperparathyroidism ameliorates gastroesophageal reflux symptoms.
    Norman J; Politz D; Lopez J; Boone D; Stojadinovic A
    World J Surg; 2015 Mar; 39(3):706-12. PubMed ID: 25409840
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Quantification of dental erosions in patients with GERD using optical coherence tomography before and after double-blind, randomized treatment with esomeprazole or placebo.
    Wilder-Smith CH; Wilder-Smith P; Kawakami-Wong H; Voronets J; Osann K; Lussi A
    Am J Gastroenterol; 2009 Nov; 104(11):2788-95. PubMed ID: 19654570
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Health Care Cost Analysis of PPI or P-CAB-First Treatment in Patients With Gastroesophageal Reflux Disease.
    Miwa H; Shiotani A; Takeda M; Eda M; Kato T; Yajima T
    J Clin Gastroenterol; 2023 Apr; 57(4):370-379. PubMed ID: 35316226
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics.
    Shimizu T; Nakayama Y; Ishii E; Ida S; Satou T; Tokuhara D; Arai K; Nii M; Rydholm H; Yajima T;
    Pediatr Int; 2019 Jan; 61(1):87-95. PubMed ID: 30422368
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis.
    Dimango E; Walker P; Keating C; Berdella M; Robinson N; Langfelder-Schwind E; Levy D; Liu X
    BMC Pulm Med; 2014 Feb; 14():21. PubMed ID: 24528942
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.
    Sun QH; Wang HY; Sun SD; Zhang X; Zhang H
    World J Gastroenterol; 2019 May; 25(17):2110-2121. PubMed ID: 31114137
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life.
    Farup C; Kleinman L; Sloan S; Ganoczy D; Chee E; Lee C; Revicki D
    Arch Intern Med; 2001 Jan; 161(1):45-52. PubMed ID: 11146697
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Comment to "predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease".
    Savarino E; Giacchino M; Brunacci M; Savarino V
    Dig Liver Dis; 2013 Oct; 45(10):868-9. PubMed ID: 23583546
    [No Abstract]   [Full Text] [Related]  

  • 114. Diamond GERD diagnosis studies: clinical feelings are good, but are measurements using a PPI test better?
    Veldhuyzen van Zanten S
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1367-8. PubMed ID: 22944730
    [No Abstract]   [Full Text] [Related]  

  • 115. Stomach myoelectrical response of patients with gastroesophageal reflux disease receiving omeprazole treatment.
    Chang FY; Lu CL; Chen CY; Luo JC; Jiun KL; Lee SD; Wu HC
    J Gastroenterol Hepatol; 2003 Dec; 18(12):1399-406. PubMed ID: 14675269
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium.
    McMahan ZH; Frech T; Berrocal V; Lim D; Bruni C; Matucci-Cerinic M; Smith V; Melsens K; Proudman S; Zhang J; Mendoza F; Woods M; Khanna D
    J Rheumatol; 2019 Jan; 46(1):78-84. PubMed ID: 30442827
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: a randomised controlled trial.
    Farup PG; Heibert M; Høeg V
    BMC Complement Altern Med; 2009 Feb; 9():3. PubMed ID: 19236727
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Age, specialty, and practice setting predict gastroesophageal reflux disease prescribing behavior.
    Lacy BE; Crowell MD; Riesett RP; Mitchell A
    J Clin Gastroenterol; 2005 Jul; 39(6):489-94. PubMed ID: 15942434
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.
    Zhuang Q; Liao A; He Q; Liu C; Zheng C; Li X; Liu Y; Wang B; Liu S; Zhang Y; Lin R; Chen H; Deng M; Tang Y; He C; Dai W; Tang H; Gong L; Li L; Xu B; Yang C; Zhou B; Su D; Guo Q; Li B; Zhou Y; Wang X; Fei S; Wu H; Wei S; Peng Z; Wang J; Li Y; Wang H; Deng T; Ding S; Li F; Chen M; Xiao Y
    J Gastroenterol Hepatol; 2024 Apr; 39(4):658-666. PubMed ID: 38251791
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux disease.
    Engels LG; Klinkenberg-Knol EC; Carlsson J; Halling K
    Health Qual Life Outcomes; 2010 Aug; 8():85. PubMed ID: 20716328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.